其他原因死亡调整对非裔美国局限性前列腺癌患者接受替代治疗方式的影响
基于SEER数据库2004-2014年260309例白人和15534例非裔美国局限性前列腺癌患者,采用多因素logistic回归分析种族间治疗率差异,并按D'Amico风险分层调整其他原因死亡(OCM)风险。调整前非裔患者接受根治性前列腺切除术(RP)的几率较低,调整OCM后RP几率反而更高,但近距离放疗(BT)和外照射放疗(EBRT)几率仍较低。结论认为非裔患者的治疗率取决于OCM风险,缺乏OCM调整可能错误提示某些治疗率较低。
要点
- 调整OCM前,非裔患者接受RP的OR在低、中、高风险组分别为0.54、0.45、0.43。
- 调整OCM后,非裔患者接受RP的OR在低、中、高风险组分别为2.58、3.07、2.67。
- 调整OCM后,非裔患者接受BT的OR在低、中、高风险组分别为0.53、0.32、0.22。
核心结论
- 对于非裔美国男性,局限性前列腺癌的治疗率取决于其他原因死亡风险。
- 缺乏其他原因死亡风险调整可能错误提示某些治疗的实施率低于白人,反之亦然。
研究设计与样本
- 基于SEER数据库(2004-2014年)识别260309例(94.0%)白人和15534例(6.0%)非裔美国前列腺癌患者。
- 采用多因素logistic回归评估按种族划分的治疗率,并按D'Amico风险分类调整或不调整其他原因死亡风险。
- 其他原因死亡风险使用多因素Cox回归模型定义,该模型在50%随机样本中开发,并在剩余50%中验证。
主要发现
- 调整其他原因死亡前,非裔患者接受RP的几率较低,低风险OR 0.54、中风险OR 0.45、高风险OR 0.43。
- 调整其他原因死亡前,非裔患者在中风险(OR 0.84)和高风险(OR 0.89)时接受BT的几率较低。
- 调整其他原因死亡后,非裔患者接受BT的OR为低风险0.53、中风险0.32、高风险0.22,接受EBRT的OR为低风险0.74、中风险0.69、高风险0.83。
- 调整其他原因死亡后,非裔患者接受RP的OR为低风险2.58、中风险3.07、高风险2.67,不再较低。
- 其他原因死亡风险Cox模型在验证队列中的准确率为74.9%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: African American (AA) men might be less likely to benefit from certain treatment types for localized prostate cancer (PCa). OBJECTIVE: To test treatment rate differences between AA and Caucasian patients with clinically localized PCa, with and without adjustment for other-cause mortality (OCM). DESIGN, SETTING, AND PARTICIPANTS: Within the Surveillance Epidemiology and End Results (SEER) database (2004-2014), we identified 260 309 (94.0%) Caucasian and 15 534 (6.0%) AA patients with PCa. INTERVENTION: Radical prostatectomy (RP), external beam radiotherapy (EBRT), brachytherapy (BT), combination of BT and EBRT (BT+EBRT), or nonlocal treatment (NLT). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We used multivariable logistic regression to assess treatment rates according to race, with or without adjustment for OCM risk according to D'Amico risk classification. OCM was defined using a multivariable Cox regression model, developed using a 50% random sample and validated using the remaining 50%. RESULTS AND LIMITATIONS: Before OCM adjustment, AA patients were less likely to receive RP regardless of D'Amico risk (odds ratio [OR] 0.54 for low risk [LR], 0.45 for intermediate risk [IR], and 0.43 for high risk [HR]) and were less likely to receive BT if D'Amico intermediate risk (OR 0.84) or high risk (OR 0.89). After OCM risk adjustment, AA men were still less likely to receive BT (OR 0.53 for LR, 0.32 for IR, 0.22 for HR) and EBRT (OR 0.74 for LR, 0.69 for IR, 0.83 for HR), but were no longer less likely to receive RP (OR 2.58 for LR, 3.07 for IR, 2.67 for HR) regardless of their D'Amico risk classification. The Cox model of OCM risk was 74.9% accurate in the validation cohort. CONCLUSIONS: For AA men, rates of treatment for localized PCa depend on OCM risk. Lack of OCM risk adjustment may incorrectly suggest that some treatments are delivered at a lower rate than for Caucasians, and vice versa. PATIENT SUMMARY: Our study critically appraised the validity of reported prostate cancer treatment rates for African American men when adjustment for other-cause mortality was not performed.
引用
- Bandini M, Preisser F, Nazzani S, et al. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients. Eur Urol Oncol. 2018. PMID: 31102624. doi:10.1016/j.euo.2018.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。